Dermatitis最新文献

英文中文

The Role of OX40-OX40L Axis in the Pathogenesis of Atopic Dermatitis. OX40-OX40L 轴在特应性皮炎发病机制中的作用

IF 5.2 3区医学 Q1 Medicine

Dermatitis

Pub Date : 2024-05-03 DOI: 10.1089/derm.2024.0058

Natale Schettini, Lucrezia Pacetti, Monica Corazza, Alessandro Borghi

OX40 is a co-stimulatory immune checkpoint molecule that promotes the activation and the effector function of T lymphocytes through interaction with its ligand (OX40L) on antigen-presenting cells. OX40-OX40L axis plays a crucial role in Th1 and Th2 cell expansion, particularly during the late phases or long-lasting response. Atopic dermatitis is characterized by an immune dysregulation of Th2 activity and by an overproduction of proinflammatory cytokines such as interleukin (IL)-4 and IL-13. Other molecules involved in its pathogenesis include thymic stromal lymphopoietin, IL-33, and IL-25, which contribute to the promotion of OX40L expression on dendritic cells. Lesional skin in atopic dermatitis exhibits a higher level of OX40L+-presenting cells compared with other dermatologic diseases or normal skin. Recent clinical trials using antagonizing anti-OX40 or anti-OX40L antibodies have shown symptom improvement and cutaneous manifestation alleviation in patients with atopic dermatitis. These findings suggest the relevance of the OX40-OX40L axis in atopic dermatitis pathogenesis.

OX40 是一种协同刺激免疫检查点分子，它通过与抗原递呈细胞上的配体（OX40L）相互作用，促进 T 淋巴细胞的活化和效应功能。OX40-OX40L 轴在 Th1 和 Th2 细胞扩增中发挥着关键作用，尤其是在晚期或持久反应期间。特应性皮炎的特点是 Th2 活性的免疫调节失调以及白细胞介素（IL）-4 和 IL-13 等促炎细胞因子的过度产生。其他参与发病的分子包括胸腺基质淋巴细胞生成素、IL-33 和 IL-25，它们有助于促进树突状细胞上 OX40L 的表达。与其他皮肤病或正常皮肤相比，特应性皮炎的病变皮肤显示出更高水平的 OX40L+ 呈递细胞。最近使用抗 OX40 或抗 OX40L 抗体进行的临床试验显示，特应性皮炎患者的症状有所改善，皮肤表现有所减轻。这些研究结果表明，OX40-OX40L 轴与特应性皮炎的发病机制有关。

{"title":"The Role of OX40-OX40L Axis in the Pathogenesis of Atopic Dermatitis.","authors":"Natale Schettini, Lucrezia Pacetti, Monica Corazza, Alessandro Borghi","doi":"10.1089/derm.2024.0058","DOIUrl":"https://doi.org/10.1089/derm.2024.0058","url":null,"abstract":"OX40 is a co-stimulatory immune checkpoint molecule that promotes the activation and the effector function of T lymphocytes through interaction with its ligand (OX40L) on antigen-presenting cells. OX40-OX40L axis plays a crucial role in Th1 and Th2 cell expansion, particularly during the late phases or long-lasting response. Atopic dermatitis is characterized by an immune dysregulation of Th2 activity and by an overproduction of proinflammatory cytokines such as interleukin (IL)-4 and IL-13. Other molecules involved in its pathogenesis include thymic stromal lymphopoietin, IL-33, and IL-25, which contribute to the promotion of OX40L expression on dendritic cells. Lesional skin in atopic dermatitis exhibits a higher level of OX40L+-presenting cells compared with other dermatologic diseases or normal skin. Recent clinical trials using antagonizing anti-OX40 or anti-OX40L antibodies have shown symptom improvement and cutaneous manifestation alleviation in patients with atopic dermatitis. These findings suggest the relevance of the OX40-OX40L axis in atopic dermatitis pathogenesis.","PeriodicalId":11047,"journal":{"name":"Dermatitis","volume":null,"pages":null},"PeriodicalIF":5.2,"publicationDate":"2024-05-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140836736","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0

Patch Test Results Among Older Adults: A Retrospective Analysis of the North American Contact Dermatitis® Group Data (2009-2020). 老年人的斑贴测试结果：北美接触性皮炎®小组数据的回顾性分析（2009-2020 年）。
IF 4 3区医学 Q1 Medicine
Dermatitis
Pub Date : 2024-05-01 Epub Date: 2023-08-17 DOI: 10.1089/derm.2023.0130

JiaDe Yu, Hadley Johnson, Joel G DeKoven, Erin M Warshaw, James S Taylor, Donald V Belsito, Brandon L Adler, Jonathan I Silverberg, Amber R Atwater, Margo J Reeder, Nina Botto, Marie-Claude Houle, Christen M Mowad, Melanie D Pratt, Cory A Dunnick

Background: Allergic contact Dermatitis® (ACD) in older adults (OA) represents a significant health burden, but few studies examine the prevalence and characteristics of contact allergy and ACD in this population. Objective: To compare positive and clinically relevant patch test results in OA versus younger adults (YA) and children. Methods: Retrospective analysis of patch test results obtained in OA (≥65 years), YA (19-64 years), and children (≤18 years) by the North American Contact Dermatitis® Group, 2009 to 2020. Results: Of 28,177 patients patch tested, 5366 (19.0%) were OA. OA were more likely to have a final primary diagnosis of ACD as compared with YA (50.8% vs 49.2%, P = 0.035) and children (44.6%, P < 0.0001). The primary site of Dermatitis® also differed by age group, with OA having a higher proportion of Dermatitis® affecting the trunk, scalp, anogenital region, and "under clothing," and a lower proportion of Dermatitis® affecting the face, lips, and feet. Limitations: Retrospective design, lack of follow-up, and referral population. Conclusion: OA were as likely and were statistically even more likely to have a final primary diagnosis of ACD compared with YA and children. Anatomic site of Dermatitis® also differed by age group. This underscores the need for patch testing in OA when ACD is suspected.

背景：老年人（OA）中的过敏性接触性皮炎（ACD）对健康造成了极大的负担，但很少有研究对这一人群中接触过敏和过敏性接触性皮炎的患病率和特征进行研究。研究目的比较 OA 与年轻成人 (YA) 和儿童的阳性和临床相关贴片测试结果。方法：回顾性分析北美接触性皮炎®小组 2009 年至 2020 年在 OA（≥65 岁）、YA（19-64 岁）和儿童（≤18 岁）中获得的斑贴测试结果。结果：在28177名接受贴片测试的患者中，5366人（19.0%）为OA。与青年（50.8% vs 49.2%，P = 0.035）和儿童（44.6%，P 限制：回顾性设计、缺乏随访和转诊人群。结论：与青少年和儿童相比，老年性痴呆症患者最终被初诊为 ACD 的几率相同，在统计学上甚至更高。皮炎®的解剖部位也因年龄组而异。这强调了在怀疑有 ACD 时对 OA 进行斑贴测试的必要性。

{"title":"Patch Test Results Among Older Adults: A Retrospective Analysis of the North American Contact Dermatitis® Group Data (2009-2020).","authors":"JiaDe Yu, Hadley Johnson, Joel G DeKoven, Erin M Warshaw, James S Taylor, Donald V Belsito, Brandon L Adler, Jonathan I Silverberg, Amber R Atwater, Margo J Reeder, Nina Botto, Marie-Claude Houle, Christen M Mowad, Melanie D Pratt, Cory A Dunnick","doi":"10.1089/derm.2023.0130","DOIUrl":"10.1089/derm.2023.0130","url":null,"abstract":"Background: Allergic contact Dermatitis® (ACD) in older adults (OA) represents a significant health burden, but few studies examine the prevalence and characteristics of contact allergy and ACD in this population. Objective: To compare positive and clinically relevant patch test results in OA versus younger adults (YA) and children. Methods: Retrospective analysis of patch test results obtained in OA (≥65 years), YA (19-64 years), and children (≤18 years) by the North American Contact Dermatitis® Group, 2009 to 2020. Results: Of 28,177 patients patch tested, 5366 (19.0%) were OA. OA were more likely to have a final primary diagnosis of ACD as compared with YA (50.8% vs 49.2%, P = 0.035) and children (44.6%, P < 0.0001). The primary site of Dermatitis® also differed by age group, with OA having a higher proportion of Dermatitis® affecting the trunk, scalp, anogenital region, and \"under clothing,\" and a lower proportion of Dermatitis® affecting the face, lips, and feet. Limitations: Retrospective design, lack of follow-up, and referral population. Conclusion: OA were as likely and were statistically even more likely to have a final primary diagnosis of ACD compared with YA and children. Anatomic site of Dermatitis® also differed by age group. This underscores the need for patch testing in OA when ACD is suspected.","PeriodicalId":11047,"journal":{"name":"Dermatitis","volume":null,"pages":null},"PeriodicalIF":4.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10011693","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0

Janus Kinase Inhibition in the Treatment of Prurigo Nodularis. Janus 激酶抑制剂治疗结节性瘙痒症
IF 4 3区医学 Q1 DERMATOLOGY
Dermatitis
Pub Date : 2024-05-01 Epub Date: 2023-08-24 DOI: 10.1089/derm.2023.0036

Sheiva Fakhraie, Raj Chovatiya

{"title":"Janus Kinase Inhibition in the Treatment of Prurigo Nodularis.","authors":"Sheiva Fakhraie, Raj Chovatiya","doi":"10.1089/derm.2023.0036","DOIUrl":"10.1089/derm.2023.0036","url":null,"abstract":"","PeriodicalId":11047,"journal":{"name":"Dermatitis","volume":null,"pages":null},"PeriodicalIF":4.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10435140","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0

Economic Costs and Implications of Occupational Skin Disease, 2011-2020. 2011-2020 年职业性皮肤病的经济成本和影响。
IF 4 3区医学 Q1 DERMATOLOGY
Dermatitis
Pub Date : 2024-05-01 Epub Date: 2023-09-05 DOI: 10.1089/derm.2023.0203

Aneesh Agarwal, Annie Chang, Nicholas Gulati

{"title":"Economic Costs and Implications of Occupational Skin Disease, 2011-2020.","authors":"Aneesh Agarwal, Annie Chang, Nicholas Gulati","doi":"10.1089/derm.2023.0203","DOIUrl":"10.1089/derm.2023.0203","url":null,"abstract":"","PeriodicalId":11047,"journal":{"name":"Dermatitis","volume":null,"pages":null},"PeriodicalIF":4.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10515640","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0

Bilateral Association Between Atopic Dermatitis® and Alopecia Areata: A Systematic Review and Meta-Analysis. 特应性皮炎®与脱发之间的双侧关联：系统回顾和元分析。
IF 4 3区医学 Q1 DERMATOLOGY
Dermatitis
Pub Date : 2024-05-01 Epub Date: 2023-07-20 DOI: 10.1089/derm.2023.0114

Rong Sun, Deqi Kong

This systematic review and meta-analysis aimed to explore the association between atopic Dermatitis® (AD) and alopecia areata (AA). A comprehensive search was conducted in PubMed, Embase, Cochrane, and Web of Science from the inception of each database to November 10, 2022 for relevant studies. As there is a potential bilateral association between the 2 diseases, we assessed the prevalence/incidence of AA in patients with AD and the prevalence/incidence of AD in patients with AA. A total of 29 studies involving 11,233,448 participants were included in this analysis. AA was the exposure factor in 23 studies, AD in 7 studies, and both in 1 study. The meta-analysis revealed that the prevalence of AD was 11.2% (7.7%-15.1%) in patients with AA, and the prevalence of AA was 3.2% (95% confidence interval [CI]: 0.0%-11.5%) in patients with AD. The incidence of AD in AA patients was found to vary with age (P = 0.07). Based on 7 studies, there was a significant association between AD and AA when AA was the exposure factor [odds ratio, OR, = 4.537 (95% CI: 2.409-8.544)]; based on 10 studies, there was also a significant association between AD and AA when AD was the exposure factor [OR = 2.643 (95% CI: 1.737-3.995)]. In conclusion, this meta-analysis demonstrated the 2-way association between AD and AA, providing a clinical reference for disease prevention and control.

本系统综述和荟萃分析旨在探讨特应性皮炎®（AD）与斑秃（AA）之间的关联。从 PubMed、Embase、Cochrane 和 Web of Science 数据库建立之初到 2022 年 11 月 10 日，我们对相关研究进行了全面检索。由于这两种疾病之间存在潜在的双边关联，我们评估了AD患者中AA的患病率/发病率以及AA患者中AD的患病率/发病率。本次分析共纳入了 29 项研究，涉及 11,233,448 名参与者。在 23 项研究中，AA 是暴露因素；在 7 项研究中，AD 是暴露因素；在 1 项研究中，两者都是暴露因素。荟萃分析显示，AA患者中AD的发病率为11.2%（7.7%-15.1%），AA患者中AA的发病率为3.2%（95%置信区间[CI]：0.0%-11.5%）。AA患者的AD发病率随年龄而变化（P = 0.07）。根据 7 项研究，当 AA 为暴露因素时，AD 与 AA 之间存在显著关联[几率比 OR = 4.537（95% CI：2.409-8.544）]；根据 10 项研究，当 AD 为暴露因素时，AD 与 AA 之间也存在显著关联[OR = 2.643（95% CI：1.737-3.995）]。总之，这项荟萃分析证明了 AD 与 AA 之间的双向关联，为疾病防治提供了临床参考。

{"title":"Bilateral Association Between Atopic Dermatitis® and Alopecia Areata: A Systematic Review and Meta-Analysis.","authors":"Rong Sun, Deqi Kong","doi":"10.1089/derm.2023.0114","DOIUrl":"10.1089/derm.2023.0114","url":null,"abstract":" This systematic review and meta-analysis aimed to explore the association between atopic Dermatitis® (AD) and alopecia areata (AA). A comprehensive search was conducted in PubMed, Embase, Cochrane, and Web of Science from the inception of each database to November 10, 2022 for relevant studies. As there is a potential bilateral association between the 2 diseases, we assessed the prevalence/incidence of AA in patients with AD and the prevalence/incidence of AD in patients with AA. A total of 29 studies involving 11,233,448 participants were included in this analysis. AA was the exposure factor in 23 studies, AD in 7 studies, and both in 1 study. The meta-analysis revealed that the prevalence of AD was 11.2% (7.7%-15.1%) in patients with AA, and the prevalence of AA was 3.2% (95% confidence interval [CI]: 0.0%-11.5%) in patients with AD. The incidence of AD in AA patients was found to vary with age (P = 0.07). Based on 7 studies, there was a significant association between AD and AA when AA was the exposure factor [odds ratio, OR, = 4.537 (95% CI: 2.409-8.544)]; based on 10 studies, there was also a significant association between AD and AA when AD was the exposure factor [OR = 2.643 (95% CI: 1.737-3.995)]. In conclusion, this meta-analysis demonstrated the 2-way association between AD and AA, providing a clinical reference for disease prevention and control.","PeriodicalId":11047,"journal":{"name":"Dermatitis","volume":null,"pages":null},"PeriodicalIF":4.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9842931","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0

Granulomatous Rosacea-Like Reaction During Dupilumab Treatment. Dupilumab治疗期间的酒糟鼻样肉芽肿反应。
IF 4 3区医学 Q1 DERMATOLOGY
Dermatitis
Pub Date : 2024-05-01 Epub Date: 2023-07-11 DOI: 10.1089/derm.2023.0126

Francesca Falcinelli, Laura Lazzeri, Noemi La Francesca, Ester Sorrentino, Martina Dragotto, Vittoria Cioppa, Pietro Rubegni, Filomena Russo

{"title":"Granulomatous Rosacea-Like Reaction During Dupilumab Treatment.","authors":"Francesca Falcinelli, Laura Lazzeri, Noemi La Francesca, Ester Sorrentino, Martina Dragotto, Vittoria Cioppa, Pietro Rubegni, Filomena Russo","doi":"10.1089/derm.2023.0126","DOIUrl":"10.1089/derm.2023.0126","url":null,"abstract":"","PeriodicalId":11047,"journal":{"name":"Dermatitis","volume":null,"pages":null},"PeriodicalIF":4.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9767027","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0

Allergic Contact Dermatitis®: A Bibliometric Analysis. 过敏性接触性皮炎®：文献计量分析。
IF 4 3区医学 Q1 DERMATOLOGY
Dermatitis
Pub Date : 2024-05-01 Epub Date: 2023-08-09 DOI: 10.1089/derm.2023.0147

Medha Rao, Shreya Deoghare, JiaDe Yu

{"title":"Allergic Contact Dermatitis®: A Bibliometric Analysis.","authors":"Medha Rao, Shreya Deoghare, JiaDe Yu","doi":"10.1089/derm.2023.0147","DOIUrl":"10.1089/derm.2023.0147","url":null,"abstract":"","PeriodicalId":11047,"journal":{"name":"Dermatitis","volume":null,"pages":null},"PeriodicalIF":4.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10372442","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0

No Causal Association Between Genetic Markers of Smoking Behaviors and Genetic Markers of Atopic Dermatitis®: Evidence From a Mendelian Randomization Study. 吸烟行为遗传标记与特应性皮炎遗传标记之间没有因果关系：孟德尔随机研究的证据
IF 4 3区医学 Q1 DERMATOLOGY
Dermatitis
Pub Date : 2024-05-01 Epub Date: 2023-08-16 DOI: 10.1089/derm.2023.0080

Yangjian Xiao, Shengbo Huang, Zhiyu Hong, Deyou Tan

{"title":"No Causal Association Between Genetic Markers of Smoking Behaviors and Genetic Markers of Atopic Dermatitis®: Evidence From a Mendelian Randomization Study.","authors":"Yangjian Xiao, Shengbo Huang, Zhiyu Hong, Deyou Tan","doi":"10.1089/derm.2023.0080","DOIUrl":"10.1089/derm.2023.0080","url":null,"abstract":"","PeriodicalId":11047,"journal":{"name":"Dermatitis","volume":null,"pages":null},"PeriodicalIF":4.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10010755","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0

First Short-Term Effectiveness and Security Data of Tralokinumab in Severe Atopic Dermatitis® in Real Clinical Practice. Tralokinumab 治疗严重特应性皮炎® 在实际临床实践中的首个短期有效性和安全性数据。
IF 4 3区医学 Q1 DERMATOLOGY
Dermatitis
Pub Date : 2024-05-01 Epub Date: 2023-05-02 DOI: 10.1089/derm.2023.0030

Rubén García Castro, Felipe Heras Mendaza, Diana Inmaculada Santiago Sánchez-Mateos, María Carmen Fariña Sabrís, Inmaculada Alcaraz León

{"title":"First Short-Term Effectiveness and Security Data of Tralokinumab in Severe Atopic Dermatitis® in Real Clinical Practice.","authors":"Rubén García Castro, Felipe Heras Mendaza, Diana Inmaculada Santiago Sánchez-Mateos, María Carmen Fariña Sabrís, Inmaculada Alcaraz León","doi":"10.1089/derm.2023.0030","DOIUrl":"10.1089/derm.2023.0030","url":null,"abstract":"","PeriodicalId":11047,"journal":{"name":"Dermatitis","volume":null,"pages":null},"PeriodicalIF":4.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9752787","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0

Herpes Zoster Infection in Atopic Patients Undergoing Upadacitinib: Practical Suggestions on Vaccination and Management. 接受阿达帕替尼治疗的特应性患者中的带状疱疹感染：关于疫苗接种和管理的实用建议。
IF 4 3区医学 Q1 DERMATOLOGY
Dermatitis
Pub Date : 2024-05-01 Epub Date: 2023-07-11 DOI: 10.1089/derm.2023.0088

Michela Ortoncelli, Luca Mastorino, Federica Gelato, Irene Richiardi, Giovanni Cavaliere, Pietro Quaglino, Simone Ribero

{"title":"Herpes Zoster Infection in Atopic Patients Undergoing Upadacitinib: Practical Suggestions on Vaccination and Management.","authors":"Michela Ortoncelli, Luca Mastorino, Federica Gelato, Irene Richiardi, Giovanni Cavaliere, Pietro Quaglino, Simone Ribero","doi":"10.1089/derm.2023.0088","DOIUrl":"10.1089/derm.2023.0088","url":null,"abstract":"","PeriodicalId":11047,"journal":{"name":"Dermatitis","volume":null,"pages":null},"PeriodicalIF":4.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9822822","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0

1

2

3

4

5

6

7

...

10

下一页尾页

类型

全部化学•材料生命科学医学物理工程技术环境•农林材料科学地球科学法学管理学化学环境科学与生态学计算机科学教育学经济学农林科学人文科学生物学数学物理与天体物理心理学综合性期刊其他工业工程理学历史学农学文学信息工程

数据库

全部 ACS Publications Elsevier ieeexplore Springer The Royal Society of Chemistry Wiley

期刊

Dermatitis

全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
﹀